Advertisement
Home Tags Human Papillomavirus (HPV)

Tag: Human Papillomavirus (HPV)

Four out of 10 girls and six out of 10 boys

CDC: Too Few U.S. Adolescents Getting HPV Vaccination

4 out of 10 girls, 6 out of 10 boys haven't started series
Human papillomavirus (HPV) type 16 DNA in oral rinses is common at diagnosis of HPV-related oropharyngeal carcinoma

HPV16 DNA in Oral Rinses at Oropharyngeal Cancer Diagnosis

But rarely seen after treatment; correlations for persistent HPV16 DNA with worse survival

CMS Finalizes Decision to Cover HPV Testing for Cervical Cancer

AAFP encouraged CMS to consider coverage and follow through on proposal
Almost a decade after the human papillomavirus vaccine was first recommended for girls

Few U.S. States Mandate Human Papillomavirus Vaccine

Immunization protects against sexually transmitted disease, certain cancers, health experts say
One dose of the human papillomavirus vaccine Cervarix could prevent as many cases of cervical cancer as the current two- and three-dose schedules

One Vaccine Dose May Adequately Protect Against HPV

Two large international trials suggest single immunization may be as good as two or three
Males benefit indirectly when girls are immunized against human papillomavirus

HPV Vaccination of Females Has Some Indirect Benefit for Males

Strongest effect on penile cancer; smallest effect on anal cancer
Quadrivalent human papillomavirus vaccination for young girls is associated with reduced incidence of dysplasia and anogenital warts

Early Benefits for Quadrivalent HPV Vaccine in Canadian Teens

Reduced incidence of dysplasia and anogenital warts among girls vaccinated in grades 8 to 9
Human leukocyte antigen expression appears to be tied to clinical outcomes in penile cancer

HLA Expression Tied to Penile Cancer Outcomes

HLA-A is an independent predictor of poor survival in HPV-negative patients
The quadrivalent human papillomavirus vaccine appears to be cost-effective for the prevention of oropharyngeal cancer among 12-year-old males

HPV4 Vaccine Cost-Effective for OPC Prevention in Teen Boys

Quadrivalent vaccine appears cost-effective among 12-year-old boys in Canada
For patients with advanced-stage esophageal squamous cell carcinoma

HPV-16 Tied to Improved Survival in Advanced Esophageal Cancer

Improved survival and treatment response for HPV-16 positive patients